enfortumab vedotin
seagen,astellas
['vedo', 'unite study', ' vedo', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'biomarker', 'bladder', 'marker ']
biomarkers of response to ev: -not a single but several potential biomarkers associated with outcomes to ev!
#gu23 #medtwitter #bladdercancer 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni